射血分数正常且舒张功能障碍患者的心肌力学
本文综述射血分数保留的心力衰竭(HFpEF)患者从临床前(A至B期)到临床(C至D期)美国心脏病学会/美国心脏协会心衰分期中左心室力学的独特模式,从细胞和肌纤维水平到 chamber 功能障碍讨论机械基础,并总结具有诊断和预后价值的生物标志物与超声心动图参数及机器学习等新型表型分析方法。
要点
- HFpEF 在普通人群中患病率高达 5.5%,预后与射血分数降低的心衰(HFrEF)相似,但缺乏已证实的疗法。
- HFpEF 患者左心室力学存在独特模式,随 ACC/AHA 心衰分期从临床前(A至B期)进展至临床(C至D期)而演变。
- 综述整合了从细胞、肌纤维到 chamber 功能障碍的力学基础,并讨论了有诊断和预后价值的生物标志物与超声心动图参数。
核心结论
- HFpEF 是一种复杂临床实体,尽管患病率可达普通人群的 5.5% 且预后与 HFrEF 相似,但目前缺乏已证实的疗法。
- 创新影像技术有助于深入理解 HFpEF 患者从临床前至临床阶段的左心室力学独特模式。
研究设计与样本
- 综述类文章,检索范围与纳入文献未在摘要中报告。
- 从细胞和肌纤维水平到 chamber 功能障碍阐述 HFpEF 的机械基础,并讨论诊断和预后相关的生物标志物与超声心动图参数。
- 纳入机器学习等新型表型分析方法,将力学特征整合为临床分组以指导患者建议和治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Heart failure with preserved ejection fraction (HFpEF) is a complex clinical entity that is poorly understood yet present in up to 5.5% of the general population. Proven therapies for this disorder are lacking, even though it has a similar prognosis to that of heart failure with reduced ejection fraction (HFrEF). Innovative imaging techniques have provided in-depth understanding of the unique pattern of left ventricular mechanics in patients with HFpEF who progress through preclinical (Stages A to B) and clinical (Stages C to D) American College of Cardiology/American Heart Association heart failure stages. This review highlights the mechanical basis of this disorder from the cellular and myofiber level to chamber dysfunction. As each chamber of the heart is examined, specific biomarkers and echocardiographic parameters with diagnostic and prognostic values are discussed. Finally, novel phenotyping methods including machine learning are reviewed that integrate these mechanics into clinical groups to advise and treat patients.
引用
- Bianco CM, Farjo PD, Ghaffar YA, et al. Myocardial Mechanics in Patients With Normal LVEF and Diastolic Dysfunction. JACC Cardiovasc Imaging. 2019. PMID: 31202770. doi:10.1016/j.jcmg.2018.12.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。